Investor Characteristics and Startups Decision

Last registered on September 20, 2021

Pre-Trial

Trial Information

General Information

Title
Investor Characteristics and Startups Decision
RCT ID
AEARCTR-0007973
Initial registration date
September 20, 2021
Last updated
September 20, 2021, 6:10 PM EDT

Locations

There are documents in this trial unavailable to the public. Use the button below to request access to this information.

Request Information

Primary Investigator

Affiliation
Columbia University

Other Primary Investigator(s)

PI Affiliation
Stanford Graduate School of Business
PI Affiliation
Hong Kong University of Science and Technology

Additional Trial Information

Status
In development
Start date
2021-10-31
End date
2022-08-31
Secondary IDs
Prior work
This trial does not extend or rely on any prior RCTs.
Abstract
This study uses a field experiment to study the discrimination and sustainable finance issues in the US venture capital industry.
External Link(s)

Registration Citation

Citation
Feng, Junlong, Ye Zhang and Weijie Zhong. 2021. "Investor Characteristics and Startups Decision." AEA RCT Registry. September 20. https://doi.org/10.1257/rct.7973-1.0
Sponsors & Partners

There are documents in this trial unavailable to the public. Use the button below to request access to this information.

Request Information
Experimental Details

Interventions

Intervention(s)
Intervention Start Date
2021-11-01
Intervention End Date
2021-11-30

Primary Outcomes

Primary Outcomes (end points)
We have four co-primary outcome variables, which are the four designed evaluation questions. Details are provided in the attached "pre-registration plan.pdf".
Primary Outcomes (explanation)

Secondary Outcomes

Secondary Outcomes (end points)
We also record the time spent on evaluating each investor profile in order to test founders' implicit bias based on gender, race or investors' ESG-related characteristics. Therefore, the evaluation time (measured in milliseconds) also serves as the outcome variable.
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
Details are provided in the attached "pre-registration plan.pdf".
Experimental Design Details
Not available
Randomization Method
Details are provided in the attached "pre-registration plan.pdf".
Randomization Unit
Details are provided in the attached "pre-registration plan.pdf".
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
1000 startup founders
Sample size: planned number of observations
20,000 observations
Sample size (or number of clusters) by treatment arms
N/A
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
IRB

Institutional Review Boards (IRBs)

IRB Name
Columbia University IRB
IRB Approval Date
2020-01-24
IRB Approval Number
Protocol 8362
Analysis Plan

There are documents in this trial unavailable to the public. Use the button below to request access to this information.

Request Information